MYL News and Press, Mylan N.V. From 04/28/20

Eagle Pharmaceuticals (NASDAQ: EGRX ) and licensee Teva Pharmaceutical Industries (NYSE: TEVA ) announce a favorable outcome in a patent dispute from would-be generic competitors to blood cancer med Bendeka (bendamustine HCl) injection. More news on: Eagle Pharmaceuticals, Inc., Teva Pha...

Mylan and Biocon Launch Fulphila®, Biosimilar Pegfilgrastim, in Canada Canada NewsWire HERTFORDSHIRE, England, PITTSBURGH and BENGALURU, India, April 28, 2020 HERTFORDSHIRE, England , PITTSBURGH and BENGALURU, India , April 28, 2020 /CNW/ --   Mylan N.V. &#x...

Mylan Gets European Union Nod for Upjohn Merger Mylan NV ( MYL ) reported that the European Union has given its approval to the company's merger with Pfizer’s ( PFE ) Upjohn. However, this antitrust clearance comes with certain caveats such as the offloading of certain assets. The E...

HERTFORDSHIRE, England and PITTSBURGH , April 24, 2020 /PRNewswire/ -- Global pharmaceutical company Mylan N.V.  (NASDAQ: MYL) today announced that it will release its first quarter 2020 financial results on Monday, May 11 , before the open of the U.S. financial markets. The...

In a statement , the FDA is cautioning against the use of malaria meds chloroquine and hydroxychloroquine outside of the hospital setting for the treatment of COVID-19 due to the risk of adverse heart rhythm side effects. More news on: Tekla World Healthcare Fund, BlackRock Health Science...

Year to date, shares of Regeneron Pharmaceuticals (NASDAQ: REGN) have gained nearly 50% despite significant declines in the overall market. Arguably, strong growth from its core pipeline consisting of Eylea (eye injection used to treat various forms of retinal disorders) and Dupixent (biol...

When  Pfizer (NYSE: PFE) announced on April 9 that its five-point plan included a promising coronavirus treatment and a potential vaccine candidate in the works, shares soared to their highest point since the beginning of March. Pfizer stock has been on an upward trajectory ever since. T...

NEW YORK , April 21, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger between Mylan N.V. (NASDAQ: MYL) and Pfizer Inc. is fair to Mylan shareholders. On July 29, 2019 , Mylan and Pfizer announced a definitive agreement to combi...

Given the resiliency of the healthcare sector in terms of economic uncertainty, I want to continue to expand my portfolio in this sector, particularly where I feel confident about the future growth years from now. This leads me to the world of biosimilars and Coherus Biosciences (NASDAQ: CHRS)...

New York City, NY: April 17, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Carboplatin Market in Global Industry: 2020 Research and New Innovations in Pharmaceuticals and Healthcare Sector. The prime objective of the report is to offer upda...